Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))

Tsunakuni Ikka; Misao Fujita; Taichi Hatta; Tetsu Isobe; Kenji Konomi; Tatsuo Onishi; Shoji Sanada; Yuichiro Sato; Shimon Tashiro; Morikuni Tobita

doi:10.1016/j.stemcr.2023.04.006

Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))

Tsunakuni Ikka, Misao Fujita, Taichi Hatta, Tetsu Isobe, Kenji Konomi, Tatsuo Onishi, Shoji Sanada, Yuichiro Sato, Shimon Tashiro, Morikuni Tobita

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

(Stem Cell Reports 18, 613–617; March 14, 2023) The authors have changed all references to “Whitelist” in the supplemental information to the term “DOAJ or Web of Science.” The reason for the change was to use a more socially fair and neutral term that does not contain discriminatory meanings or misinterpretations.

Original language	English
Pages (from-to)	1247
Number of pages	1
Journal	Stem cell reports
Volume	18
Issue number	5
DOIs	https://doi.org/10.1016/j.stemcr.2023.04.006
Publication status	Published - 2023 May 9

ASJC Scopus subject areas

Biochemistry
Genetics
Developmental Biology
Cell Biology

Access to Document

10.1016/j.stemcr.2023.04.006

Fingerprint

Dive into the research topics of 'Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))'. Together they form a unique fingerprint.

Cite this

Ikka, T., Fujita, M., Hatta, T., Isobe, T., Konomi, K., Onishi, T., Sanada, S., Sato, Y., Tashiro, S., & Tobita, M. (2023). Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013)). Stem cell reports, 18(5), 1247. https://doi.org/10.1016/j.stemcr.2023.04.006

Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013)). / Ikka, Tsunakuni; Fujita, Misao; Hatta, Taichi et al.
In: Stem cell reports, Vol. 18, No. 5, 09.05.2023, p. 1247.

Research output: Contribution to journal › Comment/debate › peer-review

Ikka, T, Fujita, M, Hatta, T, Isobe, T , Konomi, K, Onishi, T, Sanada, S, Sato, Y, Tashiro, S & Tobita, M 2023, 'Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))', Stem cell reports, vol. 18, no. 5, pp. 1247. https://doi.org/10.1016/j.stemcr.2023.04.006

Ikka T, Fujita M, Hatta T, Isobe T , Konomi K, Onishi T et al. Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013)). Stem cell reports. 2023 May 9;18(5):1247. doi: 10.1016/j.stemcr.2023.04.006

@article{0478bb98138648dcb8a84aa981d62a40,

title = "Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))",

abstract = "(Stem Cell Reports 18, 613–617; March 14, 2023) The authors have changed all references to “Whitelist” in the supplemental information to the term “DOAJ or Web of Science.” The reason for the change was to use a more socially fair and neutral term that does not contain discriminatory meanings or misinterpretations.",

author = "Tsunakuni Ikka and Misao Fujita and Taichi Hatta and Tetsu Isobe and Kenji Konomi and Tatsuo Onishi and Shoji Sanada and Yuichiro Sato and Shimon Tashiro and Morikuni Tobita",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s)",

year = "2023",

month = may,

day = "9",

doi = "10.1016/j.stemcr.2023.04.006",

language = "English",

volume = "18",

pages = "1247",

journal = "Stem cell reports",

issn = "2213-6711",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - Erratum

T2 - Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))

AU - Ikka, Tsunakuni

AU - Fujita, Misao

AU - Hatta, Taichi

AU - Isobe, Tetsu

AU - Konomi, Kenji

AU - Onishi, Tatsuo

AU - Sanada, Shoji

AU - Sato, Yuichiro

AU - Tashiro, Shimon

AU - Tobita, Morikuni

PY - 2023/5/9

Y1 - 2023/5/9

N2 - (Stem Cell Reports 18, 613–617; March 14, 2023) The authors have changed all references to “Whitelist” in the supplemental information to the term “DOAJ or Web of Science.” The reason for the change was to use a more socially fair and neutral term that does not contain discriminatory meanings or misinterpretations.

AB - (Stem Cell Reports 18, 613–617; March 14, 2023) The authors have changed all references to “Whitelist” in the supplemental information to the term “DOAJ or Web of Science.” The reason for the change was to use a more socially fair and neutral term that does not contain discriminatory meanings or misinterpretations.

UR - http://www.scopus.com/inward/record.url?scp=85156211548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85156211548&partnerID=8YFLogxK

U2 - 10.1016/j.stemcr.2023.04.006

DO - 10.1016/j.stemcr.2023.04.006

M3 - Comment/debate

C2 - 37163983

AN - SCOPUS:85156211548

SN - 2213-6711

VL - 18

SP - 1247

JO - Stem cell reports

JF - Stem cell reports

IS - 5

ER -

Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this